Skip to main content
SpringerLink
Log in

LncRNA KCNQ1OT1 acting as a ceRNA for miR-4458 enhances osteosarcoma progression by regulating CCND2 expression

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Osteosarcoma is prevalent worldwide and characterized as a challenging health burden. It has been increasingly indicated that long non-coding RNAs (lncRNAs) are significant in pathological processes of numerous cancers, exerting oncogenic or tumor-suppressive function. However, the participation of KCNQ1OT1 in osteosarcoma has not been elaborated. In this study, we focus on interrogating the function of KCNQ1OT1 and its underlying mechanism in osteosarcoma. Our work demonstrated the upregulation of KCNQ1OT1 in osteosarcoma through qRT-PCR. Besides, loss of function assay (CCK-8, transwell migration) indicated KCNQ1OT1 promoted cell proliferation, migration in osteosarcoma. Mechanically, KCNQ1OT1 acting as sponge for miR-4458 antagonized its tumor-suppressive impact on CCND2 expression. The anti-apoptotic nature of KCNQ1OT1 was also unveiled via caspase-3 activity assay. Overexpressed KCNQ1OT1 acted as competing endogenous RNA (ceRNA) for miR-4458 and subsequently reinforced target gene CCND2. Collectively, the results of rescue experiments suggested that the oncogenic role of KCNQ1OT1 was performed through sponging miR-4458 and upregulating CCND2 during osteosarcoma development, providing a novel perspective of intervention in osteosarcoma management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Ast V, Kordaß T, Oswald M, Kolte A, Eisel D, Osen W, Eichmüller SB, Berndt A, König R (2018) MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion. Oncotarget 9:35559–35580

    Article  Google Scholar 

  • Cai Y, Wan J (2018) Competing endogenous RNA regulations in neurodegenerative disorders: current challenges and emerging insights. Front Mol Neurosci 11:370

    Article  CAS  Google Scholar 

  • Chen M, Fan L, Zhang SM, Li Y, Chen P, Peng X, Liu DB, Ma C, Zhang WJ, Zou ZW, Li PD (2019) LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression. Cell Death Dis 10:70

    Article  CAS  Google Scholar 

  • Cheng C, Lu H, Wang Y (2016) miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells. Biochem Biophys Res Commun 469:37–43

    Article  Google Scholar 

  • Cheng D, Qiu X, Zhuang M, Liu Z (2018) Long noncoding RNA SNHG16 promotes cell proliferation by sponging MicroRNA-205 and upregulating ZEB1 expression in osteosarcoma. Cell Physiol Biochem 51:429–440

    Article  Google Scholar 

  • Flamini V, Dudley E, Jiang WG, Cui Y (2018) Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells. Oncotarget 9:36474–36491

    Article  Google Scholar 

  • Han W, Wang L, Zhang L, Wang Y, Li Y (2019) Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer. Biochem Biophys Res Commun 510:462–466

    Article  CAS  Google Scholar 

  • Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015) Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol 33:3029–3035

    Article  CAS  Google Scholar 

  • Jia ZW, Li Y, Cui GR, Zhao HB, Li PY, Luo JM (2018) Expression and clinical significance of LncRNA KCNQ1OT1 in patients with acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26:653–657

    PubMed  Google Scholar 

  • Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y (2018) LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer 17:119

    Article  Google Scholar 

  • Lv D-S, Li M, Sun G, Zhang X-F, Bai Y (2017) MicroRNA-4458 suppresses the proliferation of human lung cancer cells in vitro by directly targeting Lin28B. Acta Pharmacol Sin 38:1297–1304

    Article  Google Scholar 

  • Rui X, Xu Y, Jiang X, Ye W, Huang Y, Jiang J (2018) Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis. Cell Death Dis 9:1175

    Article  Google Scholar 

  • Shen F, Chang H, Gao G, Zhang B, Li X, Jin B (2018) Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis. J Cell Biochem 120:9324–9336. https://doi.org/10.1002/jcb.28208

    Article  CAS  PubMed  Google Scholar 

  • Silva JM, Rodrigues S, Sampaio-Marques B, Gomes P, Neves-Carvalho A, Dioli C, Soares-Cunha C, Mazuik BF, Takashima A, Ludovico P, Wolozin B, Sousa N, Sotiropoulos I (2018) Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology. Cell Death Differ. https://doi.org/10.1038/s41418-018-0217-1

  • Sio TT, Vu CC, Sohawon S, Van Houtte P, Thariat J, Novotny PJ, Miller RC, Bar-Sela G (2016) Extraskeletal osteosarcoma: an international rare cancer network study. Am J Clin Oncol 39:32–36

    Article  Google Scholar 

  • Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965–3981

    Article  Google Scholar 

  • Song N, Zhong J, Hu Q, Gu T, Yang B, Zhang J, Yu J, Ma X, Chen Q, Qi J, Liu Y, Su W, Feng Z, Wang X, Wang H (2018) FGF18 enhances migration and the epithelial-mesenchymal transition in breast cancer by regulating Akt/GSK3β/Β-catenin signaling. Cell Physiol Biochem 49:1019–1032

    Article  Google Scholar 

  • Su X, Teng J, Jin G, Li J, Zhao Z, Cao X, Guo Y, Guo M, Li X, Wu J, Wang C, Guo Z, Guo Q (2019) ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2. Biomed Pharmacother 109:788–797

    Article  CAS  Google Scholar 

  • Sun B, Yu H, Yang Z, Zhu L (2015) Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma. Cell Physiol Biochem 35:1797–1807

    Article  Google Scholar 

  • Tang D, Sun B, Yu H, Yang Z, Zhu L (2015) Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma. Cell Physiol Biochem 35:1797–1807

    Article  CAS  Google Scholar 

  • Wagner F, Holzapfel BM, McGovern JA, Shafiee A, Baldwin JG, Martine LC, Lahr CA, Wunner FM, Friis T, Bas O, Boxberg M, Prodinger PM, Shokoohmand A, Moi D, Mazzieri R, Loessner D, Hutmacher DW (2018) Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma. Biomaterials 171:230–246

    Article  CAS  Google Scholar 

  • Wang C, Liang C, Yang H, Chen D, Yu X, Zhao W, Geng D, Li S, Chen Z, Sun M (2018a) The dysregulated expression of KCNQ1OT1 and its interaction with downstream factors miR-145/CCNE2 in breast cancer cells. Cell Physiol Biochem 49:432–446

    Article  Google Scholar 

  • Wang D, Niu X, Wang Z, Song CL, Huang Z, Chen KN, Duan J, Bai H, Xu J, Zhao J, Wang Y, Zhuo M, Xie XS, Kang X, Tian Y, Cai L, Han JF, An T, Sun Y, Gao S, Zhao J, Ying J, Wang L, He J, Wang J (2019) Multiregion sequencing reveals the genetic heterogeneity and evolutionary history of osteosarcoma and matched pulmonary metastases. Cancer Res 79:7–20

    Article  CAS  Google Scholar 

  • Wang LY, Yu YL, Chen HW, Srivastava S, Petrovics G, Kung HJ (2014) A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A 111:18697–18702

    Article  Google Scholar 

  • Wang Z, Wu H, Xue M, Lin P, Wang S, Lin N, Huang X, Pan W, Liu M, Yan X, Qu H, Sun L, Li H, Wu Y, Teng W, Wang Z, Zhou X, Chen H, Poznansky MC, Ye Z (2018b) Epigenetic regulation of CXCL12 plays a critical role in mediating tumor progression and the immune response in osteosarcoma. Cancer Res 78:3938–3953

    Article  Google Scholar 

  • Wong KHY, Levy-Sakin M, Kwok P-Y (2018) De novo human genome assemblies reveal spectrum of alternative haplotypes in diverse populations. Nat Commun 9:3040

    Article  Google Scholar 

  • Xie Y, Sundström A, Maturi NP, Tan EJ, Marinescu VD, Jarvius M, Tirfing M, Jin C, Chen L, Essand M, Swartling FJ, Nelander S, Jiang Y, Uhrbom L (2018) LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. J Pathol 247:228–240. https://doi.org/10.1002/path.5186

    Article  CAS  Google Scholar 

  • Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X, Pan B, Xu T, Sun L, He B, Pan Y, Sun H, Wang S (2019) lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol 12:3

    Article  Google Scholar 

  • Xu R, Huang J, Zhao J, Shi W (2017) Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma. Cancer Chemother Pharmacol 80:243–250

    Article  Google Scholar 

  • Yao Y, Zhou Y, Fu X (2019) miR6713p is downregulated in nonsmall cell lung cancer and inhibits cancer progression by directly targeting CCND2. Mol Med Rep 19:2407–2412

    CAS  PubMed  Google Scholar 

  • Yu HM, Wang C, Yuan Z, Chen GL, Ye T, Yang BW (2018) LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p. Cell Prolif. https://doi.org/10.1111/cpr.12526:e12526

  • Yu W, Wang Y, Zhu J, Jin L, Liu B, Xia K, Wang J, Gao J, Liang C, Tao H (2019) Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy. Biomaterials 192:128–139

    Article  CAS  Google Scholar 

  • Zhang Y, Yang G, Luo Y (2019) Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a. Exp Ther Med 17:1337–1345

    CAS  PubMed  Google Scholar 

  • Zhao W, Li L (2019) SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. Pathol Res Pract 215:439–445

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We are thankful to all who participated in this study.

Author information

Authors and Affiliations

  1. Hand and Foot Surgical Center, Provincial Hospital Affiliated to Shandong University, Jinan, 250000, Shangdong, China

    Meng Wang, Zengtao Wang, Xiaolei Zhu, Shibing Guan & Zhibo Liu

Authors
  1. Meng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zengtao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaolei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shibing Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhibo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Meng Wang or Zhibo Liu.

Ethics declarations

The Research Ethics Committee of this hospital gave consent to this study. Prior to diagnosis, none of patients were subjected to antitumor treatment. The written consents were eligibly gained from OS patients and in line with the Declaration of Helsinki, the study was implemented.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Editor: Tetsuji Okamoto

Electronic supplementary material

Figure S1

(A) KCNQ1OT1 and CCND2 levels in OS tissues and non-OS tissues were examined via qRT-PCR analysis. (PNG 216 kb)

High resolution image (TIF 6551 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Wang, Z., Zhu, X. et al. LncRNA KCNQ1OT1 acting as a ceRNA for miR-4458 enhances osteosarcoma progression by regulating CCND2 expression. In Vitro Cell.Dev.Biol.-Animal 55, 694–702 (2019). https://doi.org/10.1007/s11626-019-00386-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-019-00386-9

Keywords

Search

Navigation